Saxony promotes biotech
This article was originally published in Clinica
Executive Summary
The German state of Saxony is consolidating its position as one of the leading international regions for biotechnology and medical research. Last week saw the opening of the interdisciplinary Max-Bergmann centre for biomaterials in Dresden. Built at a cost of E14 million ($12.4 million), the centre was established by the Dresden Institute for Polymer Research (IPF) and the Technical University of Dresden. The project was financed by the federal ministry for education and research (BMBF), the Saxon ministry for science and art and the European fund for regional development.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.